Addressing the challenge of gray-zone medicine

New England Journal of Medicine

Volumn 372, Issue 3, 2015, Pages 203-205

  Chandra, Amitabh ^a   Khullar, Dhruv ^b   Lee, Thomas H ^c  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Press Ganey Associates Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DRUG ELUTING STENT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; PATIENT IDENTIFICATION; PATIENT PREFERENCE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REIMBURSEMENT; REVASCULARIZATION; REVIEW; COST; ECONOMICS; EVIDENCE BASED MEDICINE; MYOCARDIAL INFARCTION; UTILIZATION;

COMPARATIVE EFFECTIVENESS RESEARCH; COST SHARING; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC;

EID: 84920994664     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1409696     Document Type: Article

References (6)

1. Chandra A, Skinner J. Technology growth and expenditure growth in health care. J Econ Lit 2012;50:645-80.
2. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014; 371:1208-17.
3. Erratum, N Engl J Med 2014; 371:1465. +AF0-
4. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
5. Chandra A, Jena AB, Skinner JS. The pragmatist's guide to comparative effectiveness research. J Econ Perspect 2011;25:27-46.
6. Selby JV, Lipstein SH. PCORI at 3 years - progress, lessons, and plans. N Engl J Med 2014;370:592-5.